Table 2.
Assessment of risk factors that may be linked to HPV among the respondents.
| S/No. | Research question | PHAG Gyadi-Gyadi | GGSS Gandu | Total | |||
|---|---|---|---|---|---|---|---|
| Yes | No | Yes | No | Yes (%) | No (%) | ||
| (i) | Respondents that have conducted any laboratory tests on HPV infection or cervical cancer | 0 | 200 | 0 | 200 | 0 | 400 (100) |
| (ii) | History of any experience of the presence of genital warts/skin lesions or any pain in the genital area by the respondent | 77 | 123 | 89 | 111 | 166 (41) | 234 (59) |
| (iii) | History of experiencing any form of vaginal discharge | 21 | 179 | 32 | 168 | 53 (13) | 347 (87) |
| (iv) | History of any infection associated with the genital area or urinary tract by the respondent | 44 | 156 | 47 | 153 | 91 (23) | 309 (77) |
| (v) | History of experiencing any unusual bleeding in the genital area by the respondent | 3 | 197 | 11 | 189 | 14 (4) | 386 (96) |
| (vi) | History of experiencing frequent stomach pain | 75 | 125 | 104 | 96 | 179 (45) | 221 (55) |
| (vii) | Family history of any illness associated with excessive genital bleeding | 51 | 149 | 20 | 180 | 71 (17) | 329 (82) |
| (viii) | Family history of any member ever been diagnosed with cancer | 14 | 186 | 9 | 191 | 23 (6) | 377 (94) |
PHAG, Professor Hafsat Abdullahi Ganduje Secondary School Gyadi-Gyadi; GGSS, Government Girls Secondary School Gandu.